Table 1.
Treatment | Lesion score | VH(μm) | CD(μm) | VCR |
---|---|---|---|---|
CTL | 0.14 ± 0.092a | 911.79 ± 35.44b | 121.42 ± 8.05 | 7.65 ± 0.448 |
CP | 1.57 ± 0.202b | 723.19 ± 56.30a | 101.34 ± 7.61 | 7.21 ± 0.439 |
ARGCP | 0.36 ± 0.180a | 882.36 ± 62.21b | 109.92 ± 7.76 | 7.93 ± 0.608 |
P-value | < 0.001 | 0.038 | 0.217 | 0.607 |
Values within a column followed by different superscript letters differ significantly (P < 0.05). CTL, non-challenge control; CP, C. perfringens-challenged group; ARGCP, C. perfringens-challenged group fed diet supplemented with 0.3% l-arginine. VH, villus height; CD, crypt depth; VCR, the ratio of VH:CD. Data are shown as the mean ± standard error.